80–90% of human HCC arise in the setting of a cirrhotic liver, in which HSCs have been activated [35], so we first performed IHC analysis to determine whether PDGFRα and PDGFRβ levels are elevated in human cirrhosis and HCC. The gene discussed is PDGFRA; the disease is hepatocellular carcinoma.